SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 93 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,312,000 | +17.6% | 221,300 | -4.4% | 0.00% | 0.0% |
| Q1 2016 | $2,816,000 | -3.8% | 231,598 | +25.8% | 0.00% | 0.0% |
| Q4 2015 | $2,927,000 | +188.7% | 184,137 | +177.9% | 0.00% | +100.0% |
| Q3 2015 | $1,014,000 | -63.2% | 66,267 | -41.6% | 0.00% | -50.0% |
| Q2 2015 | $2,756,000 | +125.3% | 113,445 | +115.4% | 0.00% | +100.0% |
| Q1 2015 | $1,223,000 | -44.0% | 52,657 | -39.5% | 0.00% | 0.0% |
| Q4 2014 | $2,185,000 | -8.6% | 87,084 | +13.2% | 0.00% | 0.0% |
| Q3 2014 | $2,390,000 | +41.1% | 76,924 | +17.4% | 0.00% | 0.0% |
| Q2 2014 | $1,694,000 | +232.8% | 65,536 | +199.9% | 0.00% | – |
| Q1 2014 | $509,000 | +68.5% | 21,855 | +82.9% | 0.00% | – |
| Q4 2013 | $302,000 | -43.8% | 11,952 | -54.7% | 0.00% | – |
| Q3 2013 | $537,000 | – | 26,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,495,416 | $97,301,000 | 26.57% |
| Stonepine Capital Management, LLC | 356,307 | $5,337,000 | 5.47% |
| Penn Capital Management Company, LLC | 1,841,035 | $27,673,000 | 1.57% |
| SECTORAL ASSET MANAGEMENT INC | 1,008,265 | $15,104,000 | 1.56% |
| Tamarack Advisers, LP | 259,336 | $3,885,000 | 1.49% |
| THB ASSET MANAGEMENT | 632,499 | $9,474,000 | 1.23% |
| JW Asset Management, LLC | 101,630 | $1,522,000 | 1.21% |
| Healthcare Value Capital, LLC | 50,000 | $749,000 | 0.91% |
| Kerrisdale Advisers, LLC | 190,372 | $2,851,000 | 0.77% |
| Healthcare Value Capital, LLC | 35,000 | $524,000 | 0.64% |